GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » FCF Yield %

Hemagen Diagnostics (Hemagen Diagnostics) FCF Yield % : 0.00 (As of Jun. 09, 2024)


View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Hemagen Diagnostics's Trailing 12-Month Free Cash Flow is $-0.45 Mil, and Market Cap is $0.00 Mil. Therefore, Hemagen Diagnostics's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Hemagen Diagnostics's FCF Yield % or its related term are showing as below:


HMGN's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -13.915
* Ranked among companies with meaningful FCF Yield % only.

Hemagen Diagnostics's FCF Margin % for the quarter that ended in Sep. 2012 was -6.28%.


Hemagen Diagnostics FCF Yield % Historical Data

The historical data trend for Hemagen Diagnostics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics FCF Yield % Chart

Hemagen Diagnostics Annual Data
Trend Sep03 Sep04 Sep05 Sep06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.64 -8.04 -27.52 -84.05 -82.42

Hemagen Diagnostics Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.06 -352.48 -106.01 0.64 -40.29

Competitive Comparison of Hemagen Diagnostics's FCF Yield %

For the Biotechnology subindustry, Hemagen Diagnostics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hemagen Diagnostics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemagen Diagnostics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Hemagen Diagnostics's FCF Yield % falls into.



Hemagen Diagnostics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Hemagen Diagnostics's FCF Yield % for the fiscal year that ended in Sep. 2012 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.45 / 0.5460105
=-82.42%

Hemagen Diagnostics's annualized FCF Yield % for the quarter that ended in Sep. 2012 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.055 * 4 / 0.5460105
=-40.29%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hemagen Diagnostics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Hemagen Diagnostics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
9033 Red Branch Road, Columbia, MD, USA, 21045
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.
Executives
Howard F Curd director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines